Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
24-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
24-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #52579
advertisement
Zhong H
27
Showing records 1 to 25 |
Display all abstracts from
Zhong H
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Tang Y
Heliyon
2024; 10: e25164
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Liao J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Lin J
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lai Z
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Deng W
International immunopharmacology
2024; 126: 111287
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Gao Y
Heliyon
2024; 10: e25164
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Liao J
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Yu X
Heliyon
2024; 10: e25164
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lin J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Ke D
International immunopharmacology
2024; 126: 111287
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Zhong H; Gong G
Heliyon
2024; 10: e25164
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Cui L
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang W; Qin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Zhong H
International immunopharmacology
2024; 126: 111287
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Mei F
Heliyon
2024; 10: e25164
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Huang K
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Chen Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Fan Z
Heliyon
2024; 10: e25164
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Hu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Shi Y
Heliyon
2024; 10: e25164
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Jiang L
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Cheng Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Chen Q; Xu F
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Jiang L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
«
1
2
»
Issue
24-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept